Literature DB >> 33572915

Expression of Thomsen-Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability.

Beatriz Leão1,2, Xiaogang Wen3,4, Henrique O Duarte2,4, Irene Gullo1,2,4,5,6, Gilza Gonçalves4, Patrícia Pontes4,5, Claudia Castelli7, Francisca Diniz2,4,8, Stefan Mereiter2,4, Joana Gomes2,4, Fátima Carneiro1,2,4,5,6, Celso A Reis1,2,4,6,8.   

Abstract

Microsatellite instability (MSI) is a molecular phenotype due to a deficient DNA mismatch repair (dMMR). In colorectal cancer (CRC), dMMR/MSI is associated with several clinical and histopathological features, influences prognosis, and is a predictive factor of response to therapy. In daily practice, dMMR/MSI profiles are identified by immunohistochemistry and/or multiplex PCR. The Thomsen-Friedenreich (TF) antigen was previously found to be a potential single marker to identify MSI-high gastric cancers. Therefore, in this study, we aimed to disclose a possible association between TF expression and MSI status in CRC. Furthermore, we evaluated the relationship between TF expression and other clinicopathological features, including patient survival. We evaluated the expression of the TF antigen in a cohort of 25 MSI-high and 71 microsatellite stable (MSS) CRCs. No association was observed between the expression of the TF antigen and MSI-high status in CRC. The survival analysis revealed that patients with MSI-high CRC showed improved survival when the TF antigen was expressed. This finding holds promise as it indicates the potential use of the TF antigen as a biomarker of better prognosis in MSI-high CRCs that should be validated in an independent and larger CRC cohort.

Entities:  

Keywords:  O-glycan; Thomsen–Friedenreich antigen; colorectal cancer; glycosylation; microsatellite instability

Mesh:

Substances:

Year:  2021        PMID: 33572915      PMCID: PMC7866256          DOI: 10.3390/ijms22031340

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  63 in total

Review 1.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

Review 2.  Lifestyle and dietary environmental factors in colorectal cancer susceptibility.

Authors:  Neil Murphy; Victor Moreno; David J Hughes; Ludmila Vodicka; Pavel Vodicka; Elom K Aglago; Marc J Gunter; Mazda Jenab
Journal:  Mol Aspects Med       Date:  2019-06-28

3.  Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.

Authors:  Sabine Tejpar; Zacharenia Saridaki; Mauro Delorenzi; Fred Bosman; Arnaud D Roth
Journal:  J Natl Cancer Inst       Date:  2011-05-19       Impact factor: 13.506

4.  Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. A reevaluation.

Authors:  Y Cao; U R Karsten; W Liebrich; W Haensch; G F Springer; P M Schlag
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

Review 5.  Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?

Authors:  Stefan Mereiter; Meritxell Balmaña; Diana Campos; Joana Gomes; Celso A Reis
Journal:  Cancer Cell       Date:  2019-07-08       Impact factor: 31.743

6.  Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer.

Authors:  Stefan Mereiter; Ana Magalhães; Barbara Adamczyk; Chunsheng Jin; Andreia Almeida; Lylia Drici; Maria Ibáñez-Vea; Catarina Gomes; José A Ferreira; Luis P Afonso; Lúcio L Santos; Martin R Larsen; Daniel Kolarich; Niclas G Karlsson; Celso A Reis
Journal:  Biochim Biophys Acta       Date:  2015-12-22

Review 7.  The tumour glyco-code as a novel immune checkpoint for immunotherapy.

Authors:  Ernesto RodrÍguez; Sjoerd T T Schetters; Yvette van Kooyk
Journal:  Nat Rev Immunol       Date:  2018-02-05       Impact factor: 53.106

8.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

9.  Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series.

Authors:  Maurice B Loughrey; Jason McGrath; Helen G Coleman; Peter Bankhead; Perry Maxwell; Claire McGready; Victoria Bingham; Matthew P Humphries; Stephanie G Craig; Stephen McQuaid; Manuel Salto-Tellez; Jacqueline A James
Journal:  Histopathology       Date:  2020-10-11       Impact factor: 5.087

10.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis.

Authors:  Y Ionov; M A Peinado; S Malkhosyan; D Shibata; M Perucho
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.